1.0(top 50%)
impact factor
24.6K(top 1%)
papers
61.7K(top 5%)
citations
70(top 10%)
h-index
1.1(top 50%)
extended IF
25.1K
all documents
70.5K
doc citations
107(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016Open Forum Infectious Diseases2019512
2Weight Gain After Fecal Microbiota TransplantationOpen Forum Infectious Diseases2015340
3High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019Open Forum Infectious Diseases2020336
4Treatment Options for Carbapenem-Resistant Enterobacteriaceae InfectionsOpen Forum Infectious Diseases2015328
5Increasing Infectious Endocarditis Admissions Among Young People Who Inject DrugsOpen Forum Infectious Diseases2016302
6Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations AuditOpen Forum Infectious Diseases2018278
7Coronavirus Disease 2019 Treatment: A Review of Early and Emerging OptionsOpen Forum Infectious Diseases2020259
8A Review of the Global Burden, New Diagnostics, and Current Therapeutics for AmebiasisOpen Forum Infectious Diseases2018250
9Rates of Pneumococcal Disease in Adults With Chronic Medical ConditionsOpen Forum Infectious Diseases2014214
10Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United StatesOpen Forum Infectious Diseases2020207
11C-Reactive Protein Level May Predict the Risk of COVID-19 AggravationOpen Forum Infectious Diseases2020203
12Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for CliniciansOpen Forum Infectious Diseases2015188
13The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011Open Forum Infectious Diseases2017186
14Monkeypox: A Contemporary Review for Healthcare ProfessionalsOpen Forum Infectious Diseases2022179
15Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site InfectionOpen Forum Infectious Diseases2018176
16Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Open Forum Infectious Diseases2020167
17Normal Body Temperature: A Systematic ReviewOpen Forum Infectious Diseases2019159
18Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysisOpen Forum Infectious Diseases2018156
19An “Infodemic”: Leveraging High-Volume Twitter Data to Understand Early Public Sentiment for the Coronavirus Disease 2019 OutbreakOpen Forum Infectious Diseases2020154
20Risk Factors for Herpes Zoster Infection: A Meta-AnalysisOpen Forum Infectious Diseases2020149
21Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)Open Forum Infectious Diseases2019148
22Hope on the Horizon: Novel Fungal Treatments in DevelopmentOpen Forum Infectious Diseases2020147
23Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance ProgramOpen Forum Infectious Diseases2019146
24Long COVID and Post-infective Fatigue Syndrome: A ReviewOpen Forum Infectious Diseases2021145
25Vaccine Rejection and Hesitancy: A Review and Call to ActionOpen Forum Infectious Diseases2017144
26Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and SafetyOpen Forum Infectious Diseases2019143
27Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014Open Forum Infectious Diseases2015139
28Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care NetworkOpen Forum Infectious Diseases2018139
29Postacute COVID-19: An Overview and Approach to ClassificationOpen Forum Infectious Diseases2020137
30Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19Open Forum Infectious Diseases2021135
31Adenosine Analog NITD008 Is a Potent Inhibitor of Zika VirusOpen Forum Infectious Diseases2016130
32Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance ProgramOpen Forum Infectious Diseases2019130
33Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosaOpen Forum Infectious Diseases2017123
34Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1Open Forum Infectious Diseases2015122
35Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking EraOpen Forum Infectious Diseases2021122
36Invasive Aspergillosis Associated With Severe Influenza InfectionsOpen Forum Infectious Diseases2016114
37Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective StudyOpen Forum Infectious Diseases2020112
38Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and ManagementOpen Forum Infectious Diseases2018110
39Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of LiteratureOpen Forum Infectious Diseases2017109
40Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019Open Forum Infectious Diseases2020109
41Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 PneumoniaOpen Forum Infectious Diseases2020108
42Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the LiteratureOpen Forum Infectious Diseases2018105
43Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated InfectionsOpen Forum Infectious Diseases2021105
44Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With UrosepsisOpen Forum Infectious Diseases2015103
45Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II TrialOpen Forum Infectious Diseases2015102
46Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-AnalysisOpen Forum Infectious Diseases2017102
47Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19Open Forum Infectious Diseases202099
48Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter StudyOpen Forum Infectious Diseases202197
49Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center ExperienceOpen Forum Infectious Diseases201995
50Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young AdultsOpen Forum Infectious Diseases202095